Bellus Health Stock Predictions

Healthcare > Biotechnology

Buy BLU

*Your capital is at risk

$14.74

+0 (+0%)

At Close: Sep 27, 2023

Currently predicting for Wed, 10 Jun 2026

BLU Live board

Community Bull/Bear

Target Next close

Join the BLU prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

BLU Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For BLU

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

BLU Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT BELLUS HEALTH INC.

BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. The company was incorporated in 1993 and is based in Laval, Canada....

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
EAT $140.46	7.38%	Jun 05
TPR $140.47	3.67%	Jun 04
N NVRI $19.53	8.19%	May 20
SAP $172.39	3.79%	May 05
GLBE $31.61	2.44%	May 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by